|
|
|
|
|
172
|
Mon, 8/3/09, 10:30 AM - 12:20 PM
|
CC-204A
|
|
Missing Data in Clinical Trials - Contributed - Papers
|
Biopharmaceutical Section
|
|
Chair(s): Kallappa M. Koti, FDA
|
|
10:35 AM
|
Handling Missing Data in Diabetes Studies with Rescue — Yu Chen, Merck & Co., Inc.; Bret Musser, Merck Research Laboratories
|
|
10:50 AM
|
Quantile Regression for the Decline of Lung Function in COPD Patients: A Longitudinal Study with Drop-Out — Dacheng Liu, Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
11:05 AM
|
Analysis of Dichotomized Responses in Longitudinal Studies with Missing Data — Kaifeng Lu, Merck & Co., Inc.
|
|
11:20 AM
|
Comparison of Missing Data Approaches on Noninferiority Clinical Trials in Treatment of HIV Infection — Xia Xu, Merck Research Laboratories
|
|
11:35 AM
|
Examining the Extent and the Impact of Missing Data in Oncology Clinical Trials — Mark Rothmann, FDA
|
|
11:50 AM
|
Estimating Treatment Effects in Randomized Clinical Trials with Noncompliance and Missing Outcomes — Yan Zhou, University of Michigan
|
|
12:05 PM
|
Comparison of Right and Interval Censoring Methods in Analysis of Time to Progression in Presence of Asymmetry and Missed Assessments — Somesh Chattopadhyay, FDA; Shenghui Tang, FDA; Rajeshwari Sridhara, FDA
|
| |